产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 |
CAS No. |
126128-42-5 |
|---|---|
中文名称 |
6-[(2S,4S,5R)-4-羟基-5-(羟甲基)四氢呋喃-2-基]-4,6-二氢-1H-嘧啶并[4,5-c][1,2]噁嗪-7(3H)-酮 |
英文名称 |
6-((2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4,6-dihydro-1H-pyrimido[4,5-c][1,2]oxazin-7(3H)-one |
别名 |
6-(BETA-D-2-DEOXYRIBOFURANOSYL)-3,4-DIHYDRO-8H-PYRIMIDO-[4,5-C][1,2]OXAZIN-7-ONE;6-(2-Deoxy-beta-D-erythro-pentofuranosyl)-4,6-dihydro-1H-pyrimido(4,5-C)(1,2)oxazin-7(3H)-one;6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one;6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one;6-(b-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one;1H-Pyrimido[4,5-c][1,2]oxazin-7(3H)-one, 6-(2-deoxy-β-D-erythro-pentofuranosyl)-4,6-dihydro-;6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido [4,5-c][1,2]oxazin-7-one;degenerate pyrimidine, protein mutagen |
标准英文名 |
6-((2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4,6-dihydro-1H-pyrimido[4,5-c][1,2]oxazin-7(3H)-one |
MDL No. |
MFCD01631053 |
分子式 |
C11H15N3O5 |
分子量 |
269.26 |
精确分子量 |
269.10 |
SMILES |
O=C1N=C2NOCCC2=CN1[C@@H]1C[C@H](O)[C@@H](CO)O1 |
标准SMILES |
O[C@H]1C[C@H](O[C@@H]1CO)N1C=C2CCONC2=NC1=O |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes.Not for drug or household use. |
信号词 |
Warning |
InChIKey |
YTWREPAHBKYMNI-YIZRAAEISA-N |
危险类别(旧) |
H302,H315,H319 |
存储要求 |
Inert atmosphere, 2-8°C,resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral(Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation(Category 2A) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|